Ainaz SOURATİ, Mona Malekzadeh MOGHANİ, Samira AZGHANDİ

Meme kanseri hastalarında pulmoner metastazektominin uzun dönem sonuçları ve prognostik faktörleri: Sistematik derleme

Meme kanseri, gelişmekte olan ülkelerde kadınlarda kansere bağlı ölümlerin başlıca nedenidir. Bu sistematik derlemede, meme kanserli hastalarda akciğer metastazektomisinin uzun dönem sonuçları ve prognostik faktörleri değerlendirildi. MEDLINE, Web of Science ve Scopus veri tabanlarında belirli anahtar sözcükler kullanılarak kapsamlı bir tarama yapıldı. Bu derlemeye Nisan 1990 - Nisan 2016 tarihleri arasında meme kanserli hastalarda pulmoner metastazektominin sonuçları ve prognostik faktörlerine ilişkin çalışmaların tümü dahil edildi. Çalışmaların 10’unda hastalıksız geçen süre, üçünde metastaz bölgesi, beşinde metastaz sayısı ve rezeksiyon genişliği ve altısında hormon reseptör statüsünün prognostik faktör olduğu belirlendi. Çalışma sonuçlarımıza göre, sırasıyla hastalıksız geçen süre, hormon reseptör statüsü, metastaz sayısı, metastatik rezeksiyon genişliği ve metastaz bölgesi meme kanserli hastalarda pulmoner metastazektominin önemli prognostik faktörleridir.

Long-term outcomes and prognostic factors of pulmonary metastasectomy in breast cancer patients: a systematic review

Breast cancer is the leading cause of cancer-related deaths in women in developing countries. The aim of this systematic review was to evaluate long-term outcomes and prognostic factors of pulmonary metastasectomy in patients with breast cancer. A comprehensive search was performed in the MEDLINE, Web of Science, and Scopus databases using selected keywords. All studies regarding the outcomes and prognostic factors of pulmonary metastasectomy in patients with breast cancer between April 1990 and April 2016 were included in this review. Disease-free interval was identified as a prognostic factor in 10, size of metastasis in three, number of metastases and width of resection in five, and hormone receptor status in six studies. According to our study results, disease-free interval, hormone receptor status, number of metastases, width of metastatic resection and size of metastases, in a descending order, are important prognostic factors for pulmonary metastasectomy in patients with breast cancer.

PDF

___

35. Yamamoto N, Katsumata N, Watanabe T, Omuro Y, Ando M, Narabayashi M, et al. Clinical characteristics of patients with metastatic breast cancer with complete remission following systemic treatment. Jpn J Clin Oncol 1998;28:368-73.
34. Fan J, Chen D, Du H, Shen C, Che G. Prognostic factors for resection of isolated pulmonary metastases in breast cancer patients: a systematic review and meta-analysis. J Thorac Dis 2015;7:1441-51.
33. Mimoto R, Kobayashi T, Imawari Y, Kamio M, Kato K, Nogi H, et al. Clinical relevance and low tumor-initiating properties of oligometastatic breast cancer in pulmonary metastasectomy. Breast Cancer Res Treat 2014;147:317-24.
32. Meimarakis G, Rüttinger D, Stemmler J, Crispin A, Weidenhagen R, Angele M, et al. Prolonged overall survival after pulmonary metastasectomy in patients with breast cancer. Ann Thorac Surg 2013;95:1170-80.
31. Kycler W, Laski P. Surgical approach to pulmonary metastases from breast cancer. Breast J 2012;18:52-7.
30. Yhim HY, Han SW, Oh DY, Han W, Im SA, Kim TY, et al. Prognostic factors for recurrent breast cancer patients with an isolated, limited number of lung metastases and implications for pulmonary metastasectomy. Cancer 2010;116:2890-901.
29. Chen F, Fujinaga T, Sato K, Sonobe M, Shoji T, Sakai H, et al. Clinical features of surgical resection for pulmonary metastasis from breast cancer. Eur J Surg Oncol 2009;35:393-7.
28. Yoshimoto M, Tada K, Nishimura S, Makita M, Iwase T, Kasumi F, et al. Favourable long-term results after surgical removal of lung metastases of breast cancer. Breast Cancer Res Treat 2008;110:485-91.
27. Welter S, Jacobs J, Krbek T, Tötsch M, Stamatis G. Pulmonary metastases of breast cancer. When is resection indicated? Eur J Cardiothorac Surg 2008;34:1228-34.
26. Planchard D, Soria JC, Michiels S, Grunenwald D, Validire P, Caliandro R, et al. Uncertain benefit from surgery in patients with lung metastases from breast carcinoma. Cancer 2004;100:28-35.
25. Ludwig C, Stoelben E, Hasse J. Disease-free survival after resection of lung metastases in patients with breast cancer. Eur J Surg Oncol 2003;29:532-5.
24. Simpson R, Kennedy C, Carmalt H, McCaughan B, Gillett D. Pulmonary resection for metastatic breast cancer. Aust N Z J Surg 1997;67:717-9.
23. Livartowski A, Chapelier A, Beuzedoc P, Dierick A, Asselain B, Dartevelle P, et al. Surgery of lung metastases of breast cancer: analysis of 40 cases Bull Cancer 1998;85:800.
22. Friedel G, Linder A, Toomes H. The significance of prognostic factors for the resection of pulmonary metastases of breast cancer. Thorac Cardiovasc Surg 1994;42:71-5.
21. McDonald ML, Deschamps C, Ilstrup DM, Allen MS, Trastek VF, Pairolero PC. Pulmonary resection for metastatic breast cancer. Ann Thorac Surg 1994;58:1599- 602.
20. Staren ED, Salerno C, Rongione A, Witt TR, Faber LP. Pulmonary resection for metastatic breast cancer. Arch Surg 1992;127:1282-4.
19. Lanza LA, Natarajan G, Roth JA, Putnam JB Jr. Long-term survival after resection of pulmonary metastases from carcinoma of the breast. Ann Thorac Surg 1992;54:244-7.
18. Van Raemdonck D. Pulmonary metastasectomy: common practice but is it also best practice? Future Oncol 2015;11:11-4.
17. Treasure T, Milošević M, Fiorentino F, Macbeth F. Pulmonary metastasectomy: what is the practice and where is the evidence for effectiveness? Thorax 2014;69:946-9.
16. Friedel G, Pastorino U, Ginsberg RJ, Goldstraw P, Johnston M, Pass H, et al. Results of lung metastasectomy from breast cancer: prognostic criteria on the basis of 467 cases of the International Registry of Lung Metastases. Eur J Cardiothorac Surg 2002;22:335-44.
15. Bartlett EK, Simmons KD, Wachtel H, Roses RE, Fraker DL, Kelz RR, et al. The rise in metastasectomy across cancer types over the past decade. Cancer 2015;121:747-57.
14. Wright JO, Brandt B, Ehrenhaft JL. Results of pulmonary resection for metastatic lesions. J Thorac Cardiovasc Surg 1982;83:94-9.
13. Staren ED, Salerno C, Rongione A, Witt TR, Faber LP. Pulmonary resection for metastatic breast cancer. Arch Surg 1992;127:1282-4.
12. van Dongen JA, van Slooten EA. The surgical treatment of pulmonary metastases. Cancer Treat Rev 1978;5:29-48.
11. Cardoso F, Harbeck N, Fallowfield L, Kyriakides S, Senkus E. Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2012;23:11-9.
10. Cabuk D, Basaran G, Teomete M, Dane F, Korkmaz T, Seber S, et al. Clinical outcome of Turkish metastatic breast cancer patients with currently available treatment modalities--single center experience. Asian Pac J Cancer Prev 2014;15:117-22.
9. Kreisman H, Wolkove N, Finkelstein HS, Cohen C, Margolese R, Frank H. Breast cancer and thoracic metastases: review of 119 patients. Thorax 1983;38:175-9.
8. O’Shaughnessy J. Extending survival with chemotherapy in metastatic breast cancer. Oncologist 2005;10:20-9.
7. Mousavi SM, Gouya MM, Ramazani R, Davanlou M, Hajsadeghi N, Seddighi Z. Cancer incidence and mortality in Iran. Ann Oncol 2009;20:556-63.
6. Sadjadi A, Nouraie M, Mohagheghi MA, Mousavi-Jarrahi A, Malekezadeh R, Parkin DM. Cancer occurrence in Iran in 2002, an international perspective. Asian Pac J Cancer Prev 2005;6:359-63.
5. Kolahdoozan S, Sadjadi A, Radmard AR, Khademi H. Five common cancers in Iran. Arch Iran Med 2010;13:143-6.
4. Saadat S, Yousefifard M, Asady H, Moghadas Jafari A, Fayaz M, Hosseini M. The Most Important Causes of Death in Iranian Population; a Retrospective Cohort Study. Emerg (Tehran) 2015;3:16-21.
3. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
2. Word Health Organization IAfRoC. GLOBOCAN Cancer Fact Sheets: Breast cancer - IARC. Word Health Organization; 2012 [Updated 2012; Cited]; Available from: http://globocan. iarc.fr/old/FactSheets/cancers/breast-new.asp
1. Ferlay J,Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase International Agency for Research on Cancer; 2012. Report No. 11